Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients-Reference-Cited by-同舟云学术

Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients

Published:2021-08 Issue:2 Volume:148 Page:523-532.e8
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Labrosse Roxane^ORCID,Barmettler Sara,Derfalvi Beata,Blincoe Annaliesse,Cros Guilhem,Lacombe-Barrios Jonathan,Barsalou Julie,Yang Nancy,Alrumayyan Nora,Sinclair Jan,Ong Mei-Sing,Camargo Carlos A.,Walter Jolan,Haddad Elie

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference62 articles.

1. B-cell targeted therapies in human autoimmune diseases: an updated perspective;Townsend;Immunol Rev,2010

2. Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials;Salliot;Ann Rheum Dis,2009

3. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis;Edwards;N Engl J Med,2004

4. Rituximab in the treatment of autoimmune haematological disorders;Garvey;Br J Haematol,2008

5. Outcomes of rituximab therapy in refractory lupus: A meta-analysis;Alshaiki;Eur J Rheumatol,2018

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary hypogammaglobulinemia: diagnosis and management of a pediatric condition of clinical importance;Current Opinion in Pediatrics;2024-09-03

2. Hypogammaglobulinemia and Infection Events in Patients with Autoimmune Diseases Treated with Rituximab: 10 Years Real-Life Experience;Journal of Clinical Immunology;2024-08-16

3. Early predictors of Epstein-Barr virus infection in patients with severe fever with thrombocytopenia syndrome;Virology Journal;2024-08-07

4. Dissecting Secondary Immunodeficiency: Identification of Primary Immunodeficiency within B-Cell Lymphoproliferative Disorders;2024-07-13

5. B cell depletion for autoimmune liver diseases: A retrospective review of indications and outcomes;JPGN Reports;2024-06-14